Nuclear Imaging

Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracersPET-CTSPECT-CT, and PET-MRI

blood clot detection, single scan, rats, radionuclides, Peter Caravan, whole body

The whole body of a rat can be imaged for blood clots with one PET scan (which is overlaid here on an MRI image) using the FBP8 probe. Arrow points to a blood clot. Image courtesy of Peter Caravan, Ph.D.

News | PET Imaging | September 23, 2015
September 23, 2015 — New research describes a method, tested in rats, that may someday allow healthcare providers to...
WMIS, WMIC 2015, MILabs, G-SPECT, Commerical Innovation of the Year, SPECT, PET, molecular imaging

G-SPECT photo courtesy of MILabs Inc.

News | SPECT Imaging | September 23, 2015
September 23, 2015 — The World Molecular Imaging Society (WMIS) presented the first annual Commercial Innovation of the...
Dual-energy scanning

Dual-energy scanning, achieved on Siemens’ Definition Edge, reduces severe artifacts caused by an implanted pump (left), clearly visualizing surrounding anatomical structures (right). The twin-beam, single-source Edge is one of several platforms that can characterize tissues and structures according to the atomic numbers of their elements. (Image courtesy of Siemens Healthcare)

Blog | Computed Tomography (CT) | September 22, 2015
They were once the kings of computed tomography (CT) — 16-slice scanners that hinted at coronary CT angiography; 64...
molecular imaging, imaging agent, GA-68 PSMA, improved detection, early recurrent, prostate cancer
News | Radiopharmaceuticals and Tracers | September 18, 2015
September 18, 2015 — A recently developed drug was significantly better at detecting recurring prostate cancer in early...
Novation, Mo-99, NNSA 2015 meeting, reliable supplies, domestic production
News | Radiopharmaceuticals and Tracers | September 17, 2015
September 17, 2015 — At the National Nuclear Security Administration’s (NNSA) 2015 Mo-99 Topical Meeting, Novation...
PET, imaging agent, hidden blood clots, MGH, radiopharmaceutical probe, 64Cu-FBP8
News | Radiopharmaceuticals and Tracers | September 16, 2015
September 16, 2015 — A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the...
ImaginAb, prostate imaging agent, prostate cancer, World Molecular Imaging Conference, molecular imaging, PET
News | Prostate Cancer | September 14, 2015
September 14, 2015 — ImaginAb Inc. has released interim results from a Phase 2 clinical trial of IAB2M, the company's...
Zevacor, IBA, 70 MeV cyclotron, Cyclone 70P, radiopharmaceuticals
News | Radiopharmaceuticals and Tracers | September 11, 2015
September 11, 2015 — Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET)...
News | Radiopharmaceuticals and Tracers | September 11, 2015
September 11, 2015 — Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of...
Feature | AAPM | September 08, 2015 | Melinda Taschetta-Millane
During the recent American Association of Physicists in Medicine (AAPM) conference in Anaheim, Calif., I had the...
Navidea, SBIR grant, NCI, NIH, Kaposi's sarcoma, Tc99m tilmanocept, SPECT

Image courtesy of Navidea Biopharmaceuticals Inc.

News | Radiopharmaceuticals and Tracers | September 03, 2015
September 3, 2015 — Navidea Biopharmaceuticals Inc. received initial notice of award for a Fast Track Small Business...
NorthStar Medical Radioisotopes, approval, routine production, Molybdenum-99, Mo-99, University of Missouri Research Reactor, MURR
News | Radiopharmaceuticals and Tracers | August 31, 2015
August 31, 2015 — NorthStar Medical Radioisotopes LLC has received approval to begin routine production of molybdenum-...
18F-DCFBC PET/CT
News | Prostate Cancer | August 21, 2015
August 21, 2015 — A molecular imaging biomarker is able to detect fast-growing primary prostate cancer and distinguish...
The ITM Group, in-licensing, DOTA-Zoledronate, theranostic agent, bone metastases, PET imaging
News | Radiopharmaceuticals and Tracers | August 20, 2015
August 20, 2015 — The ITM Group announced that its subsidiary ITG GmbH has successfully in-licensed DOTA-Zoledronate, a...
Lymphoseek, Navidea, injection site pain, study, breast cancer patients, tracer
News | Radiopharmaceuticals and Tracers | August 20, 2015
August 20, 2015 — Navidea Biopharmaceuticals announced publication of the results from an investigator-initiated,...
IBA Molecular North America, IBAM NA, acquisition, Illinois Health and Science, IBA S.A.
News | Radiopharmaceuticals and Tracers | August 10, 2015
August 10, 2015 — IBA (Ion Beam Applications S.A.) announced the completion of the divestiture of IBA Molecular North...
Alzheimer's Association, IDEAS Study, website, participation, brain PET scan
News | Neuro Imaging | August 05, 2015
August 5, 2015 — The Alzheimer’s Association announced the launch of a new website for the upcoming Imaging Dementia —...
biomarkers, Alzheimer's disease, AD, MRI, PET, University of Kentucky, Sanders-Brown Center on Aging
News | Neuro Imaging | July 31, 2015
July 31, 2015 — Researchers at the University of Kentucky’s Sanders-Brown Center on Aging are on the hunt for...
Navidea, Mass General, Tc99m-tilmanocept, vulnerable plaque, cardiovascular disease, Harvard
News | Radiopharmaceuticals and Tracers | July 30, 2015
July 30, 2015 — Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of...
Videos | Radiation Oncology | July 28, 2015
American Association of Physicists in Medicine (AAPM) President John Boone, Ph.D., discusses the impact of imaging in...